Opportunity Map catalyst · 2026-09-04 · version 1

    Phreesia Falls 6.3% on Q2 Net Income Shortfall Despite 10% Revenue Growth to $129.5M

    Question

    Phreesia Falls 6.3% on Q2 Net Income Shortfall Despite 10% Revenue Growth to $129.5M

    Direct answer

    Operating expense expansion and bottom-line earnings shortfall compress PHR's forward enterprise value-to-sales multiple despite double-digit top-line growth. — bearish pressure on PHR via net income margin miss on healthcare SaaS valuation multiple.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-04
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Phreesia Falls 6.3% on Q2 Net Income Shortfall Despite 10% Revenue Growth to $129.5M”, revision 1, evidence through 2026-09-04. https://marketontology.com/catalysts/2026-09-04/phreesia-falls-6-3-on-q2-net-income-shortfall-despite-10-revenue-growth-to-129-5-beb0be

    AssetDirectionTimeframeChannelScore
    PHR▼Bear1–5 daysnet income margin miss on healthcare SaaS valuation multiple
    49
    Earnings Reaction·Healthcare·Earnings·expired

    Phreesia Falls 6.3% on Q2 Net Income Shortfall Despite 10% Revenue Growth to $129.5M

    Thesis

    Operating expense expansion and bottom-line earnings shortfall compress PHR's forward enterprise value-to-sales multiple despite double-digit top-line growth. — bearish pressure on PHR via net income margin miss on healthcare SaaS valuation multiple.

    Phreesia dropped 6.33% after reporting Q2 net income of $1.9 million ($0.03/share), missing expectations.

    Transmission path
    01 · Catalyst
    Phreesia Falls 6.3% on Q2 Net Income Shortfall Despite 10% Revenue Growth to $129.5M
    02 · Mechanism
    Operating expense expansion and bottom-line earnings shortfall compress PHR's forward enterprise value-to-sales multiple despite double-digit top-line growth.
    03 · Asset response
    bearish pressure on PHR
    Source evidence
    • SourcePhreesia dropped 6.33% after reporting Q2 net income of $1.9 million ($0.03/share), missing expectations.
    • TransmissionOperating expense expansion and bottom-line earnings shortfall compress PHR's forward enterprise value-to-sales multiple despite double-digit top-line growth.
    • SummaryPhreesia shares fell 6.33% following Q2 fiscal 2027 results. Revenue grew 10% to $129.5M, topping analyst forecasts. Net income of $1.9M ($0.03/share) missed Wall Street targets.
    Possible expressions
    • PHRDirect directional or hedged short

    Illustrative, not advice

    Risks
    • Crowded positioning may already reflect the move
    • Counter-catalyst could neutralize the thesis before window closes
    • Sector rotation or peer guidance may override single-name reaction
    Invalidation
    • PHR closes above pre-catalyst level on rising volume
    • Catalyst narrative is officially walked back or contradicted
    • Cross-asset confirmation (rates / FX / vol) reverses direction
    Monitor
    • PHR price vs. pre-event level
    • PHR volume vs. 20-day average
    • Sector ETF read-through
    • Options implied volatility crush

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    Sources

    Related catalysts

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month